StockData
ImmuCell Corp logo

ImmuCell Corp (ICCC) stock

ICCCNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/303% above fair value
$11.33−0.09 (-0.79%)

Close on Nov 17, 2026Market cap $102.90MP/E 141.6Yield –

ImmuCell market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

ImmuCell's market cap was $92.55M on Nov 11, 2026, against $43.78M a year earlier. Over the last 5 years it ranged from $28.28M to $101.41M, with a median of $54.46M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$92.55M+66.4%
2025Dec 31, 2025$55.63M+22.3%
2024Dec 31, 2024$45.49M+15.4%
2023Dec 29, 2023$39.43M-16.6%
2022Dec 30, 2022$47.26M-23.7%
2021Dec 31, 2021$61.94M+44.3%
2020Dec 31, 2020$42.92M+15.6%
2019Dec 31, 2019$37.13M-3.9%
2018Dec 31, 2018$38.65M-13.0%
2017Dec 29, 2017$44.40M+91.3%
2016Dec 30, 2016$23.21M-1.6%
2015Dec 31, 2015$23.59M+58.4%
2014Dec 31, 2014$14.89M+13.0%
2013Dec 31, 2013$13.18M+7.6%
2012Dec 31, 2012$12.25M-11.4%
2011Dec 30, 2011$13.83M+46.1%
2010Dec 31, 2010$9.47M–

More ImmuCell figures

See a number that looks wrong?